Medicare Enrolled

Dr. James McCloskey, M.D.

Hematology · Hackensack, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
92 2ND ST, Hackensack, NJ 07601
5519963925
In practice since 2008 (17 years)
NPI: 1992951149 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McCloskey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McCloskey? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. McCloskey

Dr. James McCloskey is a hematology specialist in Hackensack, NJ, with 17 years of NPI registration. Based on federal Medicare data, Dr. McCloskey performed 8,800 Medicare services across 858 unique beneficiaries.

Between the years covered by Open Payments, Dr. McCloskey received a total of $2,513,499 from 41 pharmaceutical and/or device companies across 1906 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. McCloskey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 26% volume in NJ $2,513,499 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,800
Medicare services
Top 26% in NJ for hematology
858
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~518 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Epoetin alfa injection (Procrit) for anemia
An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis.
6,680 $6 $41
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
493 $146 $301
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
473 $102 $217
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
458 $107 $239
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
243 $74 $154
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
137 $12 $76
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
67 $148 $420
Bone marrow smear interpretation
A laboratory review of a bone marrow sample slide to examine cell structure and identify abnormalities.
60 $61 $332
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
40 $68 $155
New patient office visit, complex (60-74 min) 37 $182 $454
Hospital discharge day management, 30 minutes or less
This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less.
33 $70 $171
Bone marrow aspiration
A procedure to remove a small sample of liquid bone marrow for diagnostic testing.
23 $71 $578
Biopsy of bone marrow 23 $147 $624
Bone marrow biopsy and aspiration
A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions.
20 $143 $443
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
13 $111 $297
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,513,499
Total received (2018-2024)
Avg $359,071/year across 7 years
Top 2% in NJ for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
1,906
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,383,588 (94.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$127,548 (5.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,362 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$608,974
2023
$420,485
2022
$383,379
2021
$192,837
2020
$240,495
2019
$339,648
2018
$327,680

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$132,147
Takeda Pharmaceuticals U.S.A., Inc.
$106,542
Blueprint Medicines Corporation
$92,951
SOBI, INC
$59,784
E.R. Squibb & Sons, L.L.C.
$38,518
JAZZ PHARMACEUTICALS INC.
$36,137
PharmaEssentia USA Corporation
$30,789
Amgen Inc.
$30,343
Rigel Pharmaceuticals, Inc.
$23,344
Incyte Corporation
$19,605
Stemline Therapeutics Inc.
$19,404
Geron Corporation
$8,017
ABBVIE INC.
$5,483
Karyopharm Therapeutics Inc.
$2,575
TAIHO ONCOLOGY, INC.
$2,432
Celgene Corporation
$684
Daiichi Sankyo Inc.
$73
Novartis Pharmaceuticals Corporation
$50
Alexion Pharmaceuticals, Inc.
$31
Astellas Pharma US Inc
$19
PFIZER INC.
$16
Bard Peripheral Vascular, Inc.
$15
Adaptive Biotechnologies Corporation
$15
Top 3 companies account for 54.5% of 2024 payments
All-time payments by company (2018-2024) ›
Takeda Pharmaceuticals U.S.A., Inc.
$513,687
Celgene Corporation
$274,797
E.R. Squibb & Sons, L.L.C.
$229,133
Blueprint Medicines Corporation
$205,900
JAZZ PHARMACEUTICALS INC.
$149,837
GlaxoSmithKline, LLC.
$144,779
PharmaEssentia USA Corporation
$144,532
Jazz Pharmaceuticals Inc.
$132,650
Amgen Inc.
$122,254
Incyte Corporation
$120,483
Stemline Therapeutics Inc.
$107,435
CTI BioPharma Corp.
$84,111
Rigel Pharmaceuticals, Inc.
$60,788
Novartis Pharmaceuticals Corporation
$59,924
SOBI, INC
$59,784
PFIZER INC.
$28,379
AbbVie, Inc.
$16,139
Agios Pharmaceuticals, Inc.
$12,503
ABBVIE INC.
$10,658
Geron Corporation
$8,017
Gilead Sciences, Inc.
$7,250
TAIHO ONCOLOGY, INC.
$5,155
AbbVie Inc.
$4,275
Karyopharm Therapeutics Inc.
$2,575
Apellis Pharmaceuticals, Inc.
$2,360
NOVARTIS PHARMACEUTICALS CORPORATION
$1,995
Acceleron Pharma, Inc.
$1,690
Servier Pharmaceuticals LLC
$1,495
Alexion Pharmaceuticals, Inc.
$495
Daiichi Sankyo Inc.
$188
Otsuka America Pharmaceutical, Inc.
$48
Astellas Pharma US Inc
$37
GENZYME CORPORATION
$28
Genentech USA, Inc.
$20
Bard Peripheral Vascular, Inc.
$15
Spectrum Pharmaceuticals Inc.
$15
Merck Sharp & Dohme Corporation
$15
Adaptive Biotechnologies Corporation
$15
Pharmacyclics LLC, An AbbVie Company
$14
Foundation Medicine, Inc.
$12
Janssen Biotech, Inc.
$12
Top 3 companies account for 40.5% of all-time payments
Associated products mentioned in payments ›
AYVAKIT · BESPONSA · BESREMI · BOSULIF · Blincyto · DARZALEX · DAURISMO · ELITEK · ELZONRIS · EPKINLY · Empaveli · FOUNDATIONONE · Fabhalta · GLEEVEC · ICLUSIG · IDHIFA · INJECTAFER · INQOVI · INREBIC · Idhifa · Inrebic · JADENU · JAKAFI · LONSURF · MYLOTARG · Marqibo · NINLARO · NOXAFIL · Nplate · OJJAARA · ONUREG · Orserdu · Otezla · PROMACTA · REBLOZYL · RYDAPT · RYTELO · Reblozyl · Revlimid · Rezlidhia · SCEMBLIX · SOLIRIS · SPRYCEL · SYNAGIS · TASIGNA · TIBSOVO · Tavalisse · Trek · ULTOMIRIS · Ultomiris · VENCLEXTA · VONJO · VYXEOS · Vanflyta · Venclexta · Vonjo · XPOVIO · Xospata · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for hematology in NJ.

Looking for a hematology specialist in Hackensack?
Compare hematologists in the Hackensack area by procedure volume, costs, and industry payment transparency.
Browse hematologists nearby

Geographic Context

Hematologists within 10 mi
132
Per 100K population
13.8
County median income
$123,715
Nearest hospital
HACKENSACK UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. McCloskey is a mixed practice specialist, with above-average Medicare volume (top 26% in NJ), with speaking/promotional industry engagement in the top 2% of NJ peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. McCloskey experienced with epoetin alfa injection (procrit) for anemia?
Based on Medicare claims data, Dr. McCloskey performed 6,680 epoetin alfa injection (procrit) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McCloskey receive payments from pharmaceutical companies?
Yes. Dr. McCloskey received a total of $2,513,499 from 41 companies across 1,906 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McCloskey's costs compare to other hematologists in Hackensack?
Dr. McCloskey's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McCloskey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →